Newsroom
Saniona Icon blue
Latest News
October 18, 2021
PRESS RELEASE 1 8 October 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has completed the submission of all information previously requested by the U.S. Food and Drug Administration (FDA) regarding  its c hemistry,
October 6, 2021
PRESS RELEASE 6 October 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming virtual investor conferences this fall. Details are as follows: Aktiespararna’s Aktiedagen Stockholm 2021 Date/Time: 11
September 16, 2021
PRESS RELEASE 1 6 September 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of Robert E. Hoffman to its board of directors, as resolved at the extraordinary shareholders’ meeting held on September 16, 2021 .
If you have any questions regarding Saniona's media communication, feel free to contact us at any time.
trista morrison
Trista Morrison, Chief Communications Officer Phone: +1 781.810.9227 Email: trista.morrison@saniona.com